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ABSTRACT
Previously, the pyridoindole SMe1EC2 was proved to inhibit lipoperoxidation and carbonylation of proteins in rat brain cortex in the 
system Fe2+/ascorbate and improvement of resistance of the rat hippocampus was reported against ischemic conditions in vitro 
(hypoxia/hypoglycemia) expressed by the enhanced neuronal response recovery in reoxygenation. The hippocampus fulfils many 
of the criteria for a neuronal correlate of learning and memory. Recently, an impairment of hippocampal long-term potentiation 
(LTP) was reported under oxidative stress. Different therapies, including antioxidants, have been studied intensively concerning the 
impairment of neuronal plasticity. In this study marked reduction of LTP, elicited by a single burst (100 Hz, 1s) in the CA3-CA1 area 
of rat hippocampal slices, was shown due to transient hypoxia/hypoglycemia compared to control slices. On the basis of previously 
reported antioxidant and neuroprotective effects of SMe1EC2, its effect on loss of LTP in the hippocampus due to ischemic conditions 
was studied in vitro. The pyridoindole tested improved hypoxia/hypoglycemia-induced reduction of LTP compared to untreated 
hypoxic slices. An opposite effect of SMe1EC2 on LTP induction was found in control slices. The mechanism of SMe1EC2 action on 
LTP in ischemic conditions has been suggested to differ from the mechanism of its effect in “normoxia” and may be due to different 
redox status in control and ischemic brain tissue. The manifested LTP-protective effect of SMe1EC2 observed in the rat hippocampus 
exposed to ischemia in vitro may find exploitation in therapy associated with injured neuronal plasticity in some conditions, including 
ischemia, trauma and aging in man. 
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of the central nervous system during acute and chronic 
neuronal damage and aging. Traumatic brain injury pro-
duces learning and memory deficits that are thought to 
be mediated partially by impaired hippocampal function. 
Long-term potentiation (LTP), a long-lasting increase in 
synaptic strength of monosynaptic pathways in the hip-
pocampus, makes it an attractive model to study cellular 
mechanisms that may participate in learning and memory 
formation. 
Neuronal tissue is equipped with protective enzymatic 
and non-enzymatic defensive anti-oxidative mechanisms 
which offer a partial resistance to oxidative stress. 
Disturbance of the balance between the production of 
reactive oxygen species and the capacity of protective 
antioxidants produces neuronal damage. The idea of neu-
roprotective therapy for acute ischemic stroke is based on 
results from extensive studies on animal models of brain 
Introduction
Recently it has been generally accepted that oxidative 
stress is one of the multiple mechanisms participating in 
brain damage and it has been implicated in the pathogene-
sis of chronic neurodegenerative disorders like Alzheimer 
and Parkinson diseases (Keller et al., 2005; Mariani et al., 
2005; Moreira et al., 2006) and in acute brain injuries such 
as ischemia or head trauma (Sopala et al., 2000; Dai et al., 
2007; Tariq el al., 2010). Oxidative stress is believed to be 
one of the aspects contributing to a decline in function 
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ischemia, demonstrating efficacy of many natural and 
synthetic agents. Therapy using antioxidants is intensively 
studied. Contrary to positive conclusions with antioxi-
dants from experimental animal models, clinical experi-
ence failed to find neuroprotectants efficient in human 
stroke, infarction, brain trauma, tissue preservation, etc. 
Novel approaches and carefully designed trials are needed 
to disclose more potent drugs with neuroprotective and 
recovery enhancing effects (Fisher, 2011).
In the Institute of Experimental Pharmacology and 
Toxicology, Slovak Academy of Sciences, Slovakia, the 
bearing issue is focused on the search for new com-
pounds with antioxidant and antiradical properties. 
This research was based on stobadine, the compound 
revealing remarkable antioxidant, radical scavenging, 
and tissue protective action (Horáková and Štolc, 1998). 
Sites in the pyridoindole stobadine molecule responsible 
for antioxidant and antiradical properties were identified 
and new derivatives have been prepared by an appropri-
ate substitution (Štolc et al., 2008); some results have 
been included in the Slovak patent No. 287506 (Štolc et 
al., 2010). One of the new derivatives is the compound 
2-ethoxycarbonyl-8-methoxy-2,3,4,4a,5,9b-hexahydro-
1H-pyrido-[4,3b]indolinium chloride, code SMe1EC2, 
substituted with methoxy-group on the aromatic cycle 
and ethoxycarbonyl-group substituted in position 2- of 
the piperidine nitrogen. The pyridoindole SMe1EC2 was 
found to have higher antioxidant capability than the 
parent drug stobadine, at simultaneous elimination of 
the alpha1-adrenolytic activity considered as undesired 
side effect and it displayed a markedly decreased acute 
toxicity compared to stobadine after p.o., i.p. and i.v. 
administration to mice (Table 1). Beneficial effects of this 
prospective pyridoindole have been established (Štolc et 
al., 2008) and they are briefly summarized in Table 2. 
This compound revealed remarkably higher inhibitory 
effect on lipoperoxidation in rat brain homogenates in 
the presence of Fe2+/ascorbate system than did stobadine. 
Similarly , the inhibitory effect of SMe1EC2 on oxida-
tive impairment of creatine phosphokinase in rat brain 
homogenate exposed to Fe2+/ascorbate system was of 
higher potency than that of stobadine. The neuroprotec-
tive action of the pyridoindole SMe1EC2 was found also in 
the model of acute head trauma in mice where diminished 
sensomotoric impairment (expressed as “time on wire”), 
eliminated the increase in brain wet weight, which could 
be ascribed to acute brain edema. Along with this, the 
incidence of subdural bleeding, brain parenchyma bleed-
ing, and bleeding into brain chambers were significantly 
reduced in treated mice. Administration of SMe1EC2 
fully prevented a decrease in brain total glutathione 
level elicited by trauma. Recently SMe1EC2 was found to 
inhibit formation of protein carbonyl groups induced by 
the Fe2+/ascorbate system in brain cortex homogenates of 
rats (Gáspárová et al., 2010a). The improvement of neu-
ronal function recovery in reoxygenation after transient 
exposure to hypoxia/hypoglycemia of rat hippocampal 
slices was observed in several studies regardless the 
way of its administration (Gáspárová et al., 2008; 2009; 
2010b). The new pyridoindole has been suggested to apply 
its neuroprotective action in different events connected 
to oxidative injury. In this study, we examined its action 
in impairment of neuronal plasticity due to exposure to 
transient hypoxia/hypoglycemia in the rat hippocampus, 
a brain region particularly vulnerable to oxidative stress, 
yet also exceptionally plastic.
Methods
Animals
Male Wistar rats, 2 months old, weight 221 ± 11 g, n=40, 
from the breeding station Dobrá Voda (Slovak Republic, 
reg. No. SK CH 4004) were used. The rats had free access 
to water and food pellets and were kept on 12/12 h light/
dark cycle. Animals were acclimated one week prior to the 
experiments. All procedures involving animals were per-
formed in compliance with the Principles of Laboratory 
Animal Care issued by the Ethical Committee of the 
Institute of Experimental Pharmacology and Toxicology, 
Slovak Academy of Sciences and by the State Veterinary 
and Food Administration of Slovakia. 
Drug
The pyridoindole derivative SMe1EC2 was synthetized 
in the Institute of Experimental Pharmacology and 
Toxicology, Slovak Academy of Sciences, Slovakia.
Rat hippocampal slices preparation and LTP induction
The rats were briefly anesthetized by ether, decapitated 
and the hippocampus was quickly removed from the 
brain and cut into 400 μm thick slices with the McIllwain 
Table 1.  Comparison of SMe1EC2 and stobadine. 
Action SMe1EC2 Stobadine
Anti-lipoperoxidation effect 
(rat brain homogenate) pIC50 = 5.487 ± 0.014 pIC50 = 4.469 ± 0.023
Inhibition of creatine phosphokinase oxidative impairment 
(rat brain homogenate) 2.284 1 (equivalent activity)
Alpha-adrenolytic effect 
(rat aortic rings) no effect pA2 = 7.26 ± 0.12
Acute toxicity 
(mouse) 
LD50 > 2400 mg/kg, p.o.
LD50 = 1963.36 mg/kg, i.p.
LD50 = 181.13 mg/kg, i.v.
LD50 = 323.68 mg/kg, p.o.
LD50 = 164.44 mg/kg, i.p
LD50 = 63.13 mg/kg, i.v.58
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T iss u e  Ch o p pe r .  Th e  s li c es  w e r e  k e p t  in  th e  h o l ding  
chamber for at least 1-h recovery period before the experi-
ment started. During the experiments, the slice was kept 
in the recording chamber and continuously perfused with 
artificial cerebrospinal fluid (ACSF) bubbled with 95% O2 
and 5% CO2 at the constant rate monitored by aquatic 
manometer. Oxygen/glucose deprivation was obtained 
by replacing the gas mixture with O2 by the gas mixture 
with N2 by switching the valves, along with superfusion of 
the slices with ACSF equilibrated with the oxygen-free gas 
mixture and diminished glucose from 10 to 4×10–3 mol/l. 
The temperature of the recording chamber was kept at 
35.0–35.5 °C. Neurons were stimulated via Schaffer collat-
erals in the CA3 region and field excitatory postsynaptic 
potentials (fEPSPs) were recorded extracellularly from the 
pyramidal cell layer in the CA1 region. To measure base-
line synaptic transmission, the stimuli were applied every 
20 s. The stimulus intensity was reduced to 50% or less 
of the fEPSP amplitude when a population spike genera-
tion started to be detected. The slices were stabilized for 
about 15 min, the drug tested was applied during 30 min 
before high-frequency stimulation (HFS) in “normoxic” 
slices, or 30 min before transient hypoxia/hypoglycemia 
in hypoxic slices, and then during the whole experiment. 
Hypoxic slices were exposed to short 3.5 min hypoxia/
hypoglycemia followed by 20 min reoxygenation. L TP 
was induced by a single 100-Hz train with 1 000 ms train 
duration. After HFS, the baseline stimulation recording 
continued for at least 60 min. 
Statistical analysis
The electrophysiological measurements were done from 
6–10 rats in each experimental group. Three stimuli per 
minute were averaged in off-line analysis. The normalized 
value 1 represents the mean fEPSP amplitude recorded 
during a 10-min period before HFS in each slice. In the 
figures, each value represents the mean fEPSP amplitude 
(± SEM) at a given time from 6–13 hippocampal slices. 
The mean values for the last 10 min (50–60 min after 
HFS) for each group were calculated and compared. 
Statistical significance of differences between these val-
ues was established by Student´s t-test and p-values below 
0.05 were considered statistically significant.
Results
Eﬀ  ect of SMe1EC2 and LTP-induction in control 
and hypoxic rat hippocampal slices
LTP was elicited by a single burst (100  Hz, 1  s) with 
the magnitude 186.0  ±  15.8% measured within the last 
50–60  min after HFS in the control (“normoxic”) rat 
hippocampal slices, compared to the mean baseline 
fEPSP amplitude measured during 10 min before HFS. 
In the slices exposed to 3.5-min hypoxia/hypoglycemia, 
transient impairment or complete cessation of synaptic 
transmission during hypoxia was observed with almost 
complete recovery in 20-min reoxygenation (not shown). 
This short exposure of slices to hypoxia/hypoglycemia 
resulted in marked impairment of LTP (Figure 1). 
Immediately after HFS, the increase of fEPSP response 
due to HFS was smaller compared to that in control slices, 
as well as to that during further 60 min of measurement. 
The mean fEPSP amplitude within 50–60 min after HFS 
was similar to that before HFS in hypoxic slices. 
The effect of SMe1EC2 on LTP induction in hypoxic 
s l i c e s  i s  s h o w n  i n  F i g u r e  2 .  I n  t h e  c o n c e n t r a t i o n  o f  
3×10–6  mol/l a significant improvement in induction of 
LTP was observed in hypoxic slices treated by SMe1EC2 
compared to the response in hypoxic untreated slices. 
Both low concentrations of SMe 1EC2 tested failed to 
affect the impairment of LTP in the hippocampus after 
experimental ischemia in vitro. 
The compound SMe1EC2 (1×10–7; 1×10–6 mol/l), pres-
ent 30 min before HFS, appears to reduce LTP magnitude 
in “normoxic” slices 50–60 min after HFS and this reduc-
tion was significant in the highest concentration tested 
(3×10–6 mol/l, p=0.0187). The mean fEPSP amplitudes 
measured during 50–60 min after HFS are summarized 
in Figure 3. 
Table 2. Neuroprotective and antioxidant action of SMe1EC2.  
Model of injury Effect of SMe1EC2 Animal / Tissue
Fe2+/ascorbate Inhibitory effect on lipoperoxidation rat / brain homogenate 
Fe2+/ascorbate Inhibitory effect on oxidation of creatine phosphokinase rat / brain homogenate
Fe2+/ascorbate Inhibitory effect on formation of protein carbonyl groups rat / brain cortex homogenate
Acute head trauma Improvement of sensomotoric stage mouse
Acute head trauma Reduction in brain edema  mouse / brain
Acute head trauma Reduction of bleeding into brain mouse / brain
Acute head trauma Prevention of injury-induced decrease in total glutathione level mouse / brain homogenate
Acute head trauma Elimination of injury-induced increase in total lactate level mouse / brain homogenates
Hypoxia/hypoglycemia Improved recovery of neuronal response in reoxygenation rat / hippocampal slices
Hypoxia/hypoglycemia Reduction of edema rat / hippocampal slices59
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Discussion
Loss of LTP in the hippocampus was observed in trau-
matic brain injury (Miyazaki et al., 1992; Reeves et al., 
1995; Sick et al., 1998; Sanders et al., 2000; Schwarzbach 
et al., 2006), after experimental subarachnoid hemor-
rhage (Tariq et al., 2010), after ischemia (Ito et al., 1994; 
Sopala et al., 2000; Dai et al., 2007) and after hypoxia/
hypoglycemia (Gáspárová et al., 2008). In human CNS 
tissue and rodent brain similar molecular mechanisms of 
LTP were reported (Cooke & Bliss, 2006). 
The results presented in this article show that transient 
3.5-min hypoxia/hypoglycemia of rat hippocampal slices 
resulted in significant reduction of LTP. These results are 
in good agreement with the observation that extracellular 
acidosis, which is associated with several pathological 
conditions in the CNS (like ischemia, hypoxia and neu-
ronal injury), suppresses LTP induction (Velísek, 1998). 
An impairment of hippocampal LTP was also found in 
model oxidative stress induced by hydrogen peroxide in 
rats (Maalouf & Rho, 2008). 
Neuroprotection from ischemic brain damage by 
diets was examined in animal models and in humans. 
Nutritional intervention due to antioxidants and poly-
phenolic compounds from fruits, vegetables, nuts and 
grains decreases markers of oxidative damage, such as 
malondialdehyde and protein carbonyls, and decreases 
levels of proinflammatory cytokines either directly or 
indirectly by reducing oxidative damage (Gemma et al., 
2007). Vitamin E has been shown to improve age-related 
impairment in LTP (Murray & Lynch, 1998), its admin-
istration improved the learning and memory ability of 
mouse offspring whose mothers were exposed to tabacco 
smoke during pregnancy (Yang et al., 2008) and improved 
cognitive behaviors (Joseph et al., 1999; Joseph et al., 1998). 
The effect of other antioxidants on LTP-impairment was 
tested in several studies. Oxidative impairment of hip-
pocampal LTP induced by H2O2 was prevented by ketone 
bodies (Maalouf & Rho, 2008), which exert antioxidant 
effect in experimental model of neurological diseases. 
Similarly, the compound U-92032, a Ca2+ channel blocker 
and antioxidant, preserved LTP in hippocampal CA1 neu-
rons when administered to gerbils 1 h prior to bilateral 
carotid artery occlusion (Ito et al., 1994). 
Thus there are several implications about putative 
neuroprotective action of antioxidants in loss of LTP due 
to oxidative stress. We focused on the effect of the com-
pound SMe1EC2, the new pyridoindole derivative with 
antioxidant properties. Previously, the neuroprotective 
action of SMe1EC2 expressed by improved recovery of 
neuronal transmission in reoxygenation was found in rat 
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Figure 1. LTP induced by a single burst (100 Hz, 1s) in CA3-CA1 
pathway of control rat hippocampal slices (n=13) compared to 
the same response in slices (n=10) exposed to 3.5-min hypoxia/
hypoglycemia and after 20 min to high-frequency stimulation. 
Arrow shows the application of HFS. Values express mean ± SEM.
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Figure 2. LTP induced by a single burst (100 Hz, 1s) in CA3-CA1 
pathway of slices (n=10) exposed to 3.5-min hypoxia/hypogly-
cemia and after 20 min to high-frequency stimulation com-
pared with LTP in hypoxic slices treated 30 min before hypoxia/
hypoglycemia and during whole experiment by the pyridoin-
dole SMe1EC2 (1×10–7; 1×10–6; 3×10–6 mol/l; n=9; n=8; n=8, 
respectively). Arrow shows the application of HFS. Values repre-
sent mean ± SEM.60
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hippocampal slices exposed to model ischemic conditions 
in vitro. Such an improvement of functional recovery was 
observed after transient hypoxia/hypoglycemia in dif-
ferent experiments where SMe1EC2 was: (1) applied into 
superfusing medium (3×10–8–3×10–6 mol/l); (2) after 
10-day oral treatment of adult rats (50 and 250  mg/kg/
day, p.o.), and (3) in offspring after 18-day treatment of the 
mothers (50 and 250 mg/kg/day, p.o.) (Gáspárová et al., 
2008; 2009; 2010b). The present data showed improved LTP 
due to SMe1EC2 treatment in hypoxic rat hippocampal 
slices and reduction of LTP in “normoxic” slices. Similar 
results were found with melatonin, which impaired LTP 
in the dentate gyrus area of the hippocampus and induced 
learning and memory deficit in control rats (Cao et al., 
2009). Accordingly, administration of alpha-lipoic acid 
to control animals resulted in a significant impairment 
of LTP amplitude (Wang et al., 2008). The differential 
effect of antioxidants on LTP in control and hypoxic hip-
pocampal slices may be due to the different redox status 
in control and ischemic brain tissue. The neuroprotective 
effect of SMe1EC2 during hypoxia/hypoglycemia may be 
explained by its high anti-lipoperoxidation activity, which 
presumably contributes to the preservation of the neuronal 
cell membrane and to its permeability, and further by its 
inhibitory effect on carbonylation of proteins mediated by 
conditions involving oxidative stress, and thus SMe1EC2 
might protect neurons from damage of membrane lipids 
and protein receptors. The beneficial effect of SMe1EC2 
on improved LTP in treated hypoxic hippocampal slices 
probably does not act by direct interaction with glutamate 
receptor. This assumption is based on results with its par-
ent drug stobadine, which did not compete [3H]glutamate 
binding in rat brain membranes (Kvaltínová & Štolc 1997; 
Gáspárová-Kvaltínová & Štolc, 2003).
Conclusion
We conclude that the LTP-protective effect of SMe1EC2 
found in the rat hippocampus exposed to model ischemia 
may prove beneficial in therapeutic application when 
neuronal plasticity is injured in some conditions includ-
ing ischemia, trauma and aging in man. The mechanism 
of pyridoindole antioxidant effect in ischemic conditions 
may differ from the mechanism of its effect in control 
“normoxic” conditions.
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Figure 3. Normalized fEPSP amplitude measured in 50–60 min after HFS in control slices (C), control 
slices treated with SMe1EC2, hypoxic untreated slices (H) and hypoxic slices treated with SMe1EC1 in 
concentration of 1×10–7; 1×10–6 and 3×10–6 mol/l. Signifi  cant diff  erence between fEPSP amplitude in 
control slices compared to hypoxic slices (###p=0.0001), between controls and control slices treated 
with SMe1EC2 (3×10–6 mol/l) (**p=0.0187), and between hypoxic slices compared to hypoxic slices 
treated with SMe1EC2 (3×10–6 mol/l) (++p=0.0058). Signifi  cant diff  erence was calculated by Student 
t-test.
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